|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02616 CSTONE PHARMA-B
Nominal 
2.000 +0.040 (+2.041%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 105,664 | -23.642% | 138,379 | 154,166 | 39,367 | 14,185 |
| Land & other Lease Assets | 47,704 | -30.039% | 68,187 | 28,631 | 27,175 | 4,469 |
| Intangible Assets | 173,045 | 8.357% | 159,699 | 70,539 | 6,509 | 1,305 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 5,799 | -77.029% | 25,245 | 60,472 | 117,398 | 43,843 |
| 332,212 | -15.146% | 391,510 | 313,808 | 190,449 | 63,802 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 108,828 | 390.481% | 22,188 | 61,363 | 0 | 0 | |
| Trade Receivables | 172,438 | 123.559% | 77,133 | 117,598 | 0 | 0 | |
| Cash & Bank Balances | 996,671 | 78.396% | 558,684 | 742,724 | 3,024,548 | 1,126,436 | |
| Other Current Assets | 51,850 | -91.196% | 588,912 | 1,035,960 | 547,755 | 1,760,407 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 1,329,787 | 6.646% | 1,246,917 | 1,957,645 | 3,572,303 | 2,886,843 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 246,377 | -15.164% | 290,414 | 414,293 | 28,030 | 37,304 | ||
| S-T Debt & Leases | 139,313 | 210.150% | 44,918 | 43,948 | 11,314 | 4,344 | ||
| Other Current Liabilities | 464,648 | -23.972% | 611,150 | 474,707 | 687,705 | 416,316 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 850,338 | -10.158% | 946,482 | 932,948 | 727,049 | 457,964 | |||
| Net Current Assets | 479,449 | 59.585% | 300,435 | 1,024,697 | 2,845,254 | 2,428,879 | ||
| Total Assets Less Current Liabilities | 811,661 | 17.301% | 691,945 | 1,338,505 | 3,035,703 | 2,492,681 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 224,135 | -7.141% | 241,372 | 130,250 | 72,545 | 0 | |||
| Other Non-current Liabilities | 130,696 | 10380.834% | 1,247 | 1,247 | 8,698 | 11,099 | |||
| 354,831 | 46.250% | 242,619 | 131,497 | 81,243 | 11,099 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 860 | 7.232% | 802 | 796 | 787 | 687 | ||||
| Reserves | 455,970 | 1.660% | 448,524 | 1,206,212 | 2,953,673 | 2,480,895 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 456,830 | 1.670% | 449,326 | 1,207,008 | 2,954,460 | 2,481,582 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 456,830 | 1.670% | 449,326 | 1,207,008 | 2,954,460 | 2,481,582 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 0 | -- | 0 | 34,690 | 82,269 | 4,020 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 25/11/2024 10:49 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 15,699,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 0.364 |